EGF and breast carcinoma: Evidence for cross-talk between NGF or EGF and the estradiol pathways has also been demonstrated [28], and in this regard, the anti-oestrogenic drug tamoxifen can inhibit proliferation by EGF or NGF on MCF-7 breast cancer cells [29].